Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2–3 in follow up biopsies and spontaneous …

…, L Andersen, E Gudlaugsson, AC Munk… - Gynecologic …, 2011 - Elsevier
OBJECTIVE: Different Human Papilloma Virus (HPV) tests are currently used. An integrated
comparison of the Amplicor, Cobas4800, PreTect HPV-Proofer and APTIMA HPV tests has …

[HTML][HTML] HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial

…, I Baasland, GA Iversen, AC Munk… - British Journal of …, 2022 - nature.com
Background Cervical cancer screening participation is suboptimal in most settings. We
assessed whether human papillomavirus (HPV) self-sampling may increase screening …

The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2–3

…, I Skaland, A Malpica, AC Munk… - Journal of clinical …, 2011 - jcp.bmj.com
Background and aims 15–30% of cases of cervical intraepithelial neoplasia grades 2–3 (CIN2–3)
detected in punch biopsies regress spontaneously (ie, show CIN1 or less in the follow-…

Interaction of epithelial biomarkers, local immune response and condom use in cervical intraepithelial neoplasia 2–3 regression

AC Munk, E Gudlaugsson, IT Ovestad, K Lovslett… - Gynecologic …, 2012 - Elsevier
OBJECTIVE: Cervical intraepithelial neoplasia grades 2–3 (CIN2-3) are usually treated by
cone excision, although only 30% progress to cancer and 6–50% regress spontaneously. …

[HTML][HTML] High-grade cervical intraepithelial neoplasia (CIN) associates with increased proliferation and attenuated immune signaling

…, C Krakstad, M Lillesand, M Nordhus, AC Munk… - International journal of …, 2021 - mdpi.com
Implementation of high-risk human papilloma virus (HPV) screening and the increasing
proportion of HPV vaccinated women in the screening program will reduce the percentage of …

Cervical intraepithelial neoplasia grade 3 lesions can regress

AC Munk, AJAN KRUSE, B Van Diermen… - Apmis, 2007 - Wiley Online Library
Up to 30% of cervical intraepithelial grades 2–3 (CIN2–3) lesions regress, but some believe
that “regression” is due to “curative” punch biopsies. If this is true, CIN2–3 in the resection …

[HTML][HTML] A gene signature identifying CIN3 regression and cervical cancer survival

MK Halle, AC Munk, B Engesæter, S Akbari, A Frafjord… - Cancers, 2021 - mdpi.com
Simple Summary Through implementation of HPV testing as standard primary screening
method, the number of women diagnosed with high-grade cervical intraepithelial neoplasia (…

[HTML][HTML] Consistent condom use increases the regression rate of cervical intraepithelial neoplasia 2–3

AC Munk, E Gudlaugsson, A Malpica, B Fiane… - 2012 - journals.plos.org
Objective Cervical intraepithelial neoplasia grades 2-3 (CIN2-3) are usually treated by cone
excision, although only 30% progress to cancer and 6–50% regress spontaneously. The …

[HTML][HTML] Consistent condom use increases spontaneous regression in high-risk non-HPV16 but not in HPV16 CIN2-3 lesions, a prospective population-based cohort …

AC Munk, IT Øvestad, E Gudlaugsson… - Infectious agents and …, 2012 - Springer
Background The major cause of cervical intraepithelial neoplasia (CIN) is persistent infection
with human papillomavirus (HPV). Most CIN grade 2 and 3 lesions are treated with cone …

[HTML][HTML] A protein profile study to discriminate CIN lesions from normal cervical epithelium

KE Uleberg, AC Munk, I Skaland, C Furlan… - Cellular Oncology, 2011 - Springer
Background Cervical intraepithelial neoplasia (CIN), a frequently encountered disease
caused by Human Papilloma Virus (HPV) is often diagnosed in formaldehyde-fixed paraffin …